VE-cadherin/CD144 Rekombinanter Antikörper
VE-cadherin/CD144 Rekombinant Antikörper für WB, IHC, IF/ICC, IF-P, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, IF-P, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
240755D5
Kat-Nr. : 83766-6-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83766-6-PBS bindet in WB, IHC, IF/ICC, IF-P, Indirect ELISA VE-cadherin/CD144 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | VE-cadherin/CD144 fusion protein Eg1200 |
| Vollständiger Name | cadherin 5, type 2 (vascular endothelium) |
| Berechnetes Molekulargewicht | 88 kDa |
| Beobachtetes Molekulargewicht | 90-100 kDa, 130-140 kDa |
| GenBank-Zugangsnummer | NM_001795.5 |
| Gene symbol | VE-cadherin |
| Gene ID (NCBI) | 1003 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Cadherins are a family of transmembrane glycoproteins that mediate calcium-dependent cell-cell adhesion and play an important role in the maintenance of normal tissue architecture. Vascular endothelial cadherin (VE-cadherin), also known as Cadherin-5 (CDH5) or CD144, is a member of the type II classical cadherin family of cell adhesion proteins (PMID: 21269602). VE-cadherin is expressed specifically in endothelial cells and mediates homophilic adhesion in the vascular endothelium (PMID: 1522121; 8555485; 21269602). VE-cadherin plays a role in the organization of lateral endothelial junctions and in the control of permeability properties of vascular endothelium (PMID: 1522121). VE-cadherin has also been shown to be required for angiogenesis (PMID: 16473763; 18162609). The calculated molecular weight of VE-cadherin is 88 kDa and the apparent molecular weight of 120-140 kDa is higher due to post-translational glycosylation and phosphorylation (PMID: 10460833; 29894844). Full-length VE-cadherin can be proteolytically cleaved to generate a fragment of 90-100 kDa (PMID: 9786462; 22064597).











